Mexico participates in Walvax COVID-19 vaccine trials
Media
Dec 7, 2021
adn40
Trials of the Walvax vaccine against COVID-19 are being carried out in Mexico. The product is based on the mRNA, same as the moderna and pfizer vaccines. It is a biologic developed in China and 6,000 volunteers over 18 years of age are being recruited nationally.
Related Links
Aug 5, 2024
Walrinvax™ Pre-Qualified by WHO
Learn More
May 31, 2023
Walvax publishes data on safety, immunogenicity and immune persistence from the Phase 2 trial of its bivalent HPV vaccine Walrinvax™ in Human Vaccines & Immunotherapeutics
Learn More
Nov 27, 2024
Walvax’s PCV13 Officially Exported to India
Learn More